Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
about
The spread, treatment, and prevention of HIV-1: evolution of a global pandemicVirus and antibody dynamics in acute west nile virus infectionNew trends in resuscitationIdentifying Recent HIV Infections: From Serological Assays to GenomicsTransfusion transmission of HCV, a long but successful road map to safetySimultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV InfectionTransfusion-transmitted infectionsHigh levels of subgenomic HCV plasma RNA in immunosilent infectionsTesting Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence RatesA Novel Diagnostic Target in the Hepatitis C Virus GenomeCost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settingsGroup testing in heterogeneous populations by using halving algorithmsTransfusion-Transmitted InfectionsRegression analysis for multiple-disease group testing data.West Nile virus infections projected from blood donor screening data, United States, 2003HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.Strict adherence to a blood bank specimen labeling policy by all clinical laboratories significantly reduces the incidence of "wrong blood in tube".Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil.HIV Seroconversion in blood donors from the coordinating blood bank in the State of Pará.Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsPrevalence of human immunodeficiency virus, syphilis, hepatitis B and C in blood donations in Namibia.Rate of seroconversion in repeat blood donors at the national blood centre, kuala lumpur.Infectious disease markers in blood donors at Central Referral Hospital, Gangtok, SikkimDevelopment of a contemporary globally diverse HIV viral panel by the EQAPOL programProduction and new perspectives of a blood transfusion service at the Brazilian National Cancer Institute in Rio De Janeiro, Brazil.The use of pooled viral load testing to identify antiretroviral treatment failureEvaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results.Screening acute HIV infections among Chinese men who have sex with men from voluntary counseling & testing centers.Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals.Informative Retesting.Transfusion-related Listeria monocytogenes infection in a patient with acute myeloid leukaemiaScreening of HIV infection: role of molecular and immunological assays.Beyond the end of exceptionalism: integrating HIV testing into routine medical care and HIV prevention.HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.Finding those at risk: acute HIV infection in Newark, NJ.Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in São Paulo, Brazil: implications for modification of CUE policies in Brazil
P2860
Q22241890-EBD8DE30-B61D-4862-8BA1-A92E088A0B40Q24570066-D1BCA3FF-D195-430E-AEBC-F9AFC5E7BDD0Q24599047-506357D5-F516-48CB-BD53-F8996D3BCE56Q26778001-B1A7D7B0-CD5E-479F-9424-638D169A4E06Q26865471-33BABB2B-F256-4F6A-A090-4DD9A4414381Q27471998-981BEEE0-ED92-433F-88F5-3EBB207CBB30Q27480405-ACC99B1D-2FBB-4A9A-B099-B0A90198175BQ27481224-21E17EE6-2CF0-4F53-A512-FABECC13514FQ27485369-E1D307C1-D3B1-4A0E-8963-9BEDF4943C1FQ27487878-1DA5E798-8D60-47CE-A07E-B260A4DE58A1Q28475627-C0BFF0E8-EBC4-4894-AADA-9675A2B35F52Q28655740-74392A2B-470A-4B41-94B0-02D3D357B5F4Q29571219-29A27459-62A0-492C-90AB-70966E20D4B1Q30632291-E54EC8AF-D42E-4B7C-A876-455008B4FBC7Q31041026-B4AC8454-C189-4949-8DAE-41F9A32FD6A8Q33259846-5178CAAC-937C-42CE-83CA-97EB16C43225Q33288333-12B7A065-B667-4550-BA93-E2DE7EFEFA27Q33450364-E357840C-348E-4276-9C8C-0FD38B3AFB2FQ33451845-0800F782-52C9-401F-BE98-E23CB2E92923Q33452535-AB4CEF19-D9D2-4077-B669-7D8D49199D2AQ33455126-8E45B930-2FFE-43C8-8DE6-BD284289D628Q33575261-F41ADED3-A4E9-40FB-88EA-80E4953C1485Q33576779-5FE6297E-DF2B-4E47-B0A3-8DCCB0F7710BQ33619619-4D4D0320-0FDE-4C91-B1C9-2B7469490ECFQ33760732-56E79FA1-CD73-418C-85C2-C97A880100D3Q33922689-DB1812C6-E325-4DDB-91D9-4A7754350337Q33962413-9A035DF1-8412-405B-A81D-DABE78E468B3Q34043003-D6E5D9BF-367D-48B1-ABB8-ED7FD11CC06DQ34070855-09D76398-D741-4EC4-B57D-9CE3DFABE882Q34110368-D041F567-B4AA-4095-B211-81CED879DE60Q34195386-646F4DA1-FB4D-4A2D-B8B3-719C6BF2F43AQ34353231-E7F2C0E0-1D36-4C6E-81A5-EEC14199E399Q34416416-9BC84167-88F9-4DB6-BA70-DDA207137A6FQ34527302-E4676FFE-EF6E-4464-8FE3-D2D6B3CE5825Q34659704-504EA916-AD7C-4288-8A89-C8EC755B00C1Q34699130-691D306A-D4EE-420B-A5B7-CFC593411314Q34701577-A94DE575-D6C2-48AB-B507-23C86E44E754Q35018065-04CA9D1A-333A-41FB-8496-213127B91FAEQ35019884-8EC39F7B-C5B1-4C20-8CA4-F4F1C08B9CFFQ35205771-BFC94A34-585A-4750-9858-463DE5C97426
P2860
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@en
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@nl
type
label
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@en
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@nl
prefLabel
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@en
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@nl
P2093
P356
P1476
Detection of HIV-1 and HCV inf ...... ic acid-amplification testing.
@en
P2093
D Michael Strong
David J Wright
National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group
Roger Y Dodd
Sally Caglioti
Simone A Glynn
Steven H Kleinman
P304
P356
10.1056/NEJMOA040085
P407
P577
2004-08-01T00:00:00Z